Rare Disease CRO Services | Cromos Pharma Introduction to Rare Disease CRO Support A rare disease is defined differently across regulatory regions. Rare diseases affect an estimated 30 million people in the EU (roughly 1 in 17, or 4% of the population) and over 30 million in the U.S. (1 in 10 Americans). These definitions enable incentives such as market exclusivity, tax credits, Read more
oncology cro
Oncology CRO: How to Choose the Right Partner for Clinical Trials An oncology CRO is a contract research organization that specializes in the planning, management, and execution of clinical trials for cancer therapies. These studies require specialized operational expertise because of complex protocols, biomarker-defined patient populations, evolving standards of care, intensive safety monitoring, and strong competition for eligible patients. Oncology drug development is evolving rapidly as Read more
World Kidney Day 2026 | What Sponsors Should Know About the Future of Kidney Trials | Cromos Pharma
World Kidney Day 2026 | What Sponsors Should Know About the Future of Kidney Trials As World Kidney Day 2026 is marked around the world, kidney disease is increasingly moving to the forefront of global healthcare discussions. Read more
Clinical Research Focus. 50th Edition Clinical Research Focus featuring topical articles of interest to the clinical trial community. Explore the news of January 2026. Read more

Schedule a meeting

We are excited to connect with you, understand your goals, and explore how we can support your needs.

Contact us